EQPT
EquipmentShare.com Inc.
EQPT has a slight edge over RKLB overall, supported by lower modeled downside.
RKLB
Rocket Lab USA, Inc.
RKLB offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
EQPT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Under pressure | |
| Weak |
EQPT's revenue and profitability are currently healthy, but its cash flow and balance sheet are under pressure.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
EQPT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $15.43 | — |
| Current | 108x | $15.43 | — |
| Cheap | 167x | $23.43 | +52% |
| Fair | 210x | $29.38 | +90% |
| Expensive | 228x | $31.95 | +107% |
Historical ranges are pointers, not guarantees.
EQPT's PE is 108x, but its earnings don't support one, so it isn't a reliable read right now.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
EQPT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect EQPT to return to profit, with revenue growing. However, they disagree widely on these estimates.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
EQPT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.72 | +414% |
| Q3 2026 | $0.14 | +$0.23 |
| Q2 2026 | $0.09 | +$0.20 |
EQPT has the edge over RKLB in the latest year-over-year earnings comparison.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
EQPT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +56% |
| Q2 2026 | $1.4B | +26% |
| Q1 2026 | $989M | +38% |
| Q4 2025 | $1.6B | +1.2% |
| Q3 2025 | $943.9M | +22% |
EQPT's revenue has grown year over year every quarter since late 2025: $1.5B last quarter, up 56% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8% | +1.1 points |
| Q2 2026 | 6.5% | +1 points |
| Q1 2026 | 0.1% | +1.5 points |
| Q4 2025 | 11% | +3.6 points |
| Q3 2025 | 6.9% | -1.1 points |
| Q2 2025 | 5.5% | N/A |
| Q1 2025 | -1.4% | N/A |
| Q4 2024 | 7.8% | N/A |
EQPT has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over EQPT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
EQPT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$37M | +$438.6M |
| Q2 2026 | -$378M | +$280.1M |
| Q1 2026 | -$576M | -$172M |
| Q4 2025 | -$256.1M | +$134.2M |
| Q3 2025 | -$475.6M | -$205.2M |
| Q2 2025 | -$658.1M | -$391.9M |
| Q1 2025 | -$404M | -$137.8M |
EQPT has the edge over RKLB on cash flow, with more consistent year-over-year improvement.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
EQPT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.6x | High |
| Q2 2026 | 5.5x | High |
| Q1 2026 | 5.2x | High |
| Q4 2025 | 5.5x | High |
| Q3 2025 | 7.7x | High |
| Q2 2025 | 5.8x | High |
EQPT's net debt is about 4.6 years of its operating earnings (EBITDA), down from 7.7 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
EQPT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.1 | Neutral |
| Stochastic | 32.9 | Neutral |
EQPT's weekly RSI is 40 (neutral) and its Stochastic is 33 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
EQPT PE vs Industrials Sector
| Metric | EQPT | Sector median | Relative |
|---|---|---|---|
| PE | 108x | 24x | 348% above |
EQPT is trading at 108x earnings, a 348% premium to the Industrials sector's median of 24x, though its earnings don't support one.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
EQPT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $16.0 | 3.4% below |
| 20 week MA | $17.7 | 13% below |
RKLB has stronger trend alignment. EQPT is above 0 of 2 weekly averages versus RKLB above 3 of 5.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
EQPT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $32.6 | $15.4 | -53% |
It's down 53% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over EQPT on returns for 2026, with the stronger performance.